Neuroma, Acoustic

神经瘤,声学
  • 文章类型: Journal Article
    一些前庭神经鞘瘤(VS)表现为囊性形态。众所周知,与手术治疗中的实体VS相比,这些囊性VS具有不同的风险特征。尽管如此,目前还没有一项直接的比较研究比较SRS和SURGERY在囊性VS中的有效性.这项回顾性双中心队列研究旨在分析在显微外科(SURGERY)和立体定向放射外科(SRS)的双中心研究中,囊性VS与实体VS的治疗。囊性形态定义为在介入前MRI中存在任何大小的T2高强度和钆对比剂阴性囊肿。通过确定匹配的SURGERY处理的固体VS和SRS处理的固体VS的亚组进行匹配的亚组分析。功能状态,然后比较介入后肿瘤体积大小。从2005年到2011年,在两个研究地点都接受了N=901例原发性和孤立性VS患者的治疗。其中,6%为囊性形态。囊性VS的发生率随肿瘤大小而增加:KoosI中的1.75%,KoosII中的4.07%,KoosIII中的4.84%,KoosIV发病率最高,为15.43%。与实体VS相比,囊性VS的分流依赖性明显更高(p=0.024),与实体VS相比,囊性VS患者的Charlson合并症指数(CCI)明显更差(p<0.001)。囊性VS的GTR率为87%,因此显着降低,与固体VS中的96%相比(p=0.037)。与匹配的实体VS相比,SRS后动态体积变化(减少和增加)的发生率在囊性VS中明显更常见(p=0.042)。囊性VS中SRS的肿瘤进展发生率为25%。当比较外科治疗的囊性与实性VS中的EOR时,GTR的肿瘤复发率为4%,显著低于STR的50%(p=0.042).囊性VS中的肿瘤控制优于外科手术,当高度切除级别治疗时,与SRS相比。与实性VS相比,囊性SRS的治疗反应较差。然而,当通过手术治疗囊性VS时,GTR的比率低于整体,和坚实的VS队列。在囊性VS中,患有相关术后面神经麻痹的患者人数显着增加,而不是唯一的囊性形态。囊性VS应在专门中心进行手术治疗。
    Some vestibular schwannoma (VS) show cystic morphology. It is known that these cystic VS bear different risk profiles compared to solid VS in surgical treatment. Still, there has not been a direct comparative study comparing both SRS and SURGERY effectiveness in cystic VS. This retrospective bi-center cohort study aims to analyze the management of cystic VS compared to solid VS in a dual center study with both microsurgery (SURGERY) and stereotactic radiosurgery (SRS). Cystic morphology was defined as presence of any T2-hyperintense and Gadolinium-contrast-negative cyst of any size in the pre-interventional MRI. A matched subgroup analysis was carried out by determining a subgroup of matched SURGERY-treated solid VS and SRS-treated solid VS. Functional status, and post-interventional tumor volume size was then compared. From 2005 to 2011, N = 901 patients with primary and solitary VS were treated in both study sites. Of these, 6% showed cystic morphology. The incidence of cystic VS increased with tumor size: 1.75% in Koos I, 4.07% in Koos II, 4.84% in Koos III, and the highest incidence with 15.43% in Koos IV. Shunt-Dependency was significantly more often in cystic VS compared to solid VS (p = 0.024) and patients with cystic VS presented with significantly worse Charlson Comorbidity Index (CCI) compared to solid VS (p < 0.001). The rate of GTR was 87% in cystic VS and therefore significantly lower, compared to 96% in solid VS (p = 0.037). The incidence of dynamic volume change (decrease and increase) after SRS was significantly more common in cystic VS compared to the matched solid VS (p = 0.042). The incidence of tumor progression with SRS in cystic VS was 25%. When comparing EOR in the SURGERY-treated cystic to solid VS, the rate for tumor recurrence was significantly lower in GTR with 4% compared to STR with 50% (p = 0.042). Tumor control in cystic VS is superior in SURGERY, when treated with a high extent of resection grade, compared to SRS. Therapeutic response of SRS was worse in cystic compared to solid VS. However, when cystic VS was treated surgically, the rate of GTR is lower compared to the overall, and solid VS cohort. The significantly higher number of patients with relevant post-operative facial palsy in cystic VS is accredited to the increased tumor size not its sole cystic morphology. Cystic VS should be surgically treated in specialized centers.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:每种新一代手机技术都引发了有关暴露于射频电磁场(RF-EMF)的潜在致癌性的讨论。现有证据不足以得出长期大量使用手机的结论,受限于差异召回和选择偏差,或粗略的暴露评估。手机与健康队列研究(COSMOS)是专门为克服这些缺点而设计的。
    方法:我们招募了丹麦的参与者,芬兰,荷兰,瑞典,和英国2007-2012年。基线问卷评估了手机使用的生命周期。参与者通过基于人群的癌症登记来识别神经胶质瘤,脑膜瘤,随访期间的听神经瘤病例。通过根据自我报告的数据和基线时客观的操作员记录信息,通过回归校准方法调整移动电话通话时间的估计值,可以减少非差异暴露错误分类。神经胶质瘤的危险比(HR)和95%置信区间(CI),脑膜瘤,使用Cox回归模型以年龄为基础的时间尺度来估计与手机使用终生史有关的听神经瘤,根据国家调整,性别,教育水平,和婚姻状况。
    结果:264,574名参与者累计1,836,479人年。在7.12年的中位随访期间,149胶质瘤,89脑膜瘤,29例听神经瘤。对于神经胶质瘤,每100个回归校准的手机通话时间累积小时数的校正HR为1.00(95%CI0.98-1.02),脑膜瘤为1.01(95%CI0.96-1.06),听神经瘤为1.02(95%CI0.99-1.06)。对于神经胶质瘤,≥1908年回归校正的累积小时数(第90百分位分数)的HR为1.07(95%CI0.62-1.86).超过15年的手机使用与肿瘤风险增加无关;对于神经胶质瘤,HR为0.97(95%CI0.62-1.52)。
    结论:我们的研究结果表明,使用手机的累积量与发生神经胶质瘤的风险无关,脑膜瘤,或者听神经瘤.
    BACKGROUND: Each new generation of mobile phone technology has triggered discussions about potential carcinogenicity from exposure to radiofrequency electromagnetic fields (RF-EMF). Available evidence has been insufficient to conclude about long-term and heavy mobile phone use, limited by differential recall and selection bias, or crude exposure assessment. The Cohort Study on Mobile Phones and Health (COSMOS) was specifically designed to overcome these shortcomings.
    METHODS: We recruited participants in Denmark, Finland, the Netherlands, Sweden, and the UK 2007-2012. The baseline questionnaire assessed lifetime history of mobile phone use. Participants were followed through population-based cancer registers to identify glioma, meningioma, and acoustic neuroma cases during follow-up. Non-differential exposure misclassification was reduced by adjusting estimates of mobile phone call-time through regression calibration methods based on self-reported data and objective operator-recorded information at baseline. Hazard ratios (HR) and 95% confidence intervals (CI) for glioma, meningioma, and acoustic neuroma in relation to lifetime history of mobile phone use were estimated with Cox regression models with attained age as the underlying time-scale, adjusted for country, sex, educational level, and marital status.
    RESULTS: 264,574 participants accrued 1,836,479 person-years. During a median follow-up of 7.12 years, 149 glioma, 89 meningioma, and 29 incident cases of acoustic neuroma were diagnosed. The adjusted HR per 100 regression-calibrated cumulative hours of mobile phone call-time was 1.00 (95 % CI 0.98-1.02) for glioma, 1.01 (95 % CI 0.96-1.06) for meningioma, and 1.02 (95 % CI 0.99-1.06) for acoustic neuroma. For glioma, the HR for ≥ 1908 regression-calibrated cumulative hours (90th percentile cut-point) was 1.07 (95 % CI 0.62-1.86). Over 15 years of mobile phone use was not associated with an increased tumour risk; for glioma the HR was 0.97 (95 % CI 0.62-1.52).
    CONCLUSIONS: Our findings suggest that the cumulative amount of mobile phone use is not associated with the risk of developing glioma, meningioma, or acoustic neuroma.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    目的:手术切除前庭神经鞘瘤(前庭神经鞘瘤切除术;VSR)导致单侧前庭功能减退,伴有头晕和失衡。虽然解剖损伤是永久性的,平衡的恢复和头晕的减少发生通过中枢神经生理补偿。系统的补偿是通过日常活动来维持的。不幸的是,刺激的中断,例如由于疾病导致的活动减少,会导致代偿失调。代偿失调被描述为与最初的侮辱/伤害期间所经历的症状一致的症状恢复(例如,头晕,示波器,平衡难度)。这项病例研究描述了一名有VSR病史的人在住院和从COVID-19感染中恢复后,前庭功能障碍的复发。它进一步记录了她的康复,这可能是前庭康复的结果。
    方法:一名49岁女性(M.W.),有VSR手术史(10年前),有明显的COVID-19感染病史,导致重症监护病房住院和长期使用补充氧气,出现持续的头晕和失衡的物理治疗。视频头脉冲测试证实了单侧前庭功能减退。
    方法:M.W.参加为期6周的双周前庭康复,并完成每日家庭锻炼。
    结果:出院时,M.W.证明了患者报告结果的改善(头晕障碍清单),功能测试(MiniBEST,2分钟步行测试),和凝视稳定性措施(视频头部脉冲测试,动态视力)。
    结论:由COVID-19感染引起的前庭代偿失调导致功能活动性显著下降。针对凝视和姿势稳定性的前庭康复可有效减轻症状,并促进恢复至M.W.COVID-19之前的功能水平。视频摘要可从作者那里获得更多见解(请参阅视频,补充数字内容1可在http://链接上获得。www.com/JNPT/A458)。
    OBJECTIVE: Surgical removal of a vestibular schwannoma (vestibular schwannoma resection; VSR) results in a unilateral vestibular hypofunction with complaints of dizziness and imbalance. Although the anatomic lesion is permanent, recovery of balance and diminution of dizziness occurs through central neurophysiologic compensation. Compensation of the system is maintained through daily activity. Unfortunately, interruption of stimulus, such as decreased activities due to illness, can cause decompensation. Decompensation is described as the return of symptoms consistent with that experienced during the initial insult/injury (eg, dizziness, oscillopsia, balance difficulty). This case study describes a reoccurrence of vestibular dysfunction in a person with a history of VSR following hospitalization and protracted recovery from a COVID-19 infection. It further documents her recovery that may be a result of vestibular rehabilitation.
    METHODS: A 49-year-old woman (M.W.) with a surgical history of VSR (10 years prior) and a medical history of significant COVID-19 infection, resulting in an intensive care unit stay and prolonged use of supplemental oxygen, presented to physical therapy with persistent dizziness and imbalance. The video head impulse test confirmed unilateral vestibular hypofunction.
    METHODS: M.W. attended biweekly vestibular rehabilitation for 6 weeks and completed daily home exercises.
    RESULTS: At discharge, M.W. demonstrated improvements in patient-reported outcomes (Dizziness Handicap Inventory), functional testing (MiniBEST, 2-Minute Walk Test), and gaze stability measures (video head impulse testing, dynamic visual acuity).
    CONCLUSIONS: Vestibular decompensation preluded by a COVID-19 infection caused a significant decrease in functional mobility. Vestibular rehabilitation targeted at gaze and postural stability effectively reduced symptoms and facilitated recovery to M.W.\'s pre-COVID-19 level of function. Video Abstract available for more insights from the authors (see the Video, Supplemental Digital Content 1 available at: http://links.lww.com/JNPT/A458 ).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:验证在外部同质数据集上开发的前庭神经鞘瘤(VS)分割自动模型在应用于内部异构数据时的性能。
    方法:外部数据集包括242名先前未经治疗的患者,接受伽玛刀放射外科治疗的零星单侧VS,使用均匀磁共振成像(MRI)扫描。内部数据集包括我们机构的10名患者,不同类型的MRI扫描。
    方法:在外部数据集上开发了自动VS分割模型。在内部数据集上对模型进行了测试。
    方法:骰子得分,衡量地面真相和预测分割之间的一致性。
    结果:应用于患者内部扫描时,自动化模型在所有10张图像中获得了61%的平均骰子得分。有三个未检测到的肿瘤。这些肿瘤平均为0.01ml(SD=0.00ml)。检测到的七个肿瘤的平均Dice评分为87%(SD=14%)。在进一步审查这次扫描时,有一个异常值,骰子为55%,发现高强度的岩骨已包括在肿瘤分割中。
    结论:我们表明,使用限制性的孤立机构数据集开发的自动分割模型可以成功地适应来自不同成像系统和患者人群的数据。这是朝着验证自动VS分割迈出的重要一步。然而,有明显的缺陷,可能反映了用于训练模型的数据的局限性。需要进一步验证以使VS的自动分割变得可概括。
    OBJECTIVE: To validate how an automated model for vestibular schwannoma (VS) segmentation developed on an external homogeneous dataset performs when applied to internal heterogeneous data.
    METHODS: The external dataset comprised 242 patients with previously untreated, sporadic unilateral VS undergoing Gamma Knife radiosurgery, with homogeneous magnetic resonance imaging (MRI) scans. The internal dataset comprised 10 patients from our institution, with heterogeneous MRI scans.
    METHODS: An automated VS segmentation model was developed on the external dataset. The model was tested on the internal dataset.
    METHODS: Dice score, which measures agreement between ground truth and predicted segmentations.
    RESULTS: When applied to the internal patient scans, the automated model achieved a mean Dice score of 61% across all 10 images. There were three tumors that were not detected. These tumors were 0.01 ml on average (SD = 0.00 ml). The mean Dice score for the seven tumors that were detected was 87% (SD = 14%). There was one outlier with Dice of 55%-on further review of this scan, it was discovered that hyperintense petrous bone had been included in the tumor segmentation.
    CONCLUSIONS: We show that an automated segmentation model developed using a restrictive set of siloed institutional data can be successfully adapted for data from different imaging systems and patient populations. This is an important step toward the validation of automated VS segmentation. However, there are significant shortcomings that likely reflect limitations of the data used to train the model. Further validation is needed to make automated segmentation for VS generalizable.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    这项研究的目的是初步探讨手术的安全性,功效,技术,和完全神经内镜手术通过乙状窦后入路切除桥小脑角(CPA)肿瘤的临床价值。回顾性分析2014年6月至2023年6月采用全神经内镜手术治疗的47例桥小脑角区(CPA)肿瘤的临床资料。根据手术时间等指标评估手术技术的疗效和优势,神经内镜技术,术中神经和血管的完整性,肿瘤切除范围,结果或术后症状,和并发症的发生率。47例桥小脑角肿瘤包括34例表皮样囊肿,前庭神经鞘瘤7例,脑膜瘤6例。所有患者均接受完全神经内镜手术。使用单刀两手技术切除了20个肿瘤,使用两名外科医生的四手技术切除了27个肿瘤。在所有47例中,受影响的颅神经的解剖完整性均得到保留。没有病人术后出血,脑脊液漏,无菌性或化脓性脑膜炎,或死亡。肿瘤总切除率为72.3%(34/47),症状改善率为89.4%(42/47)。所有患者均随访2~12个月。没有人死亡,也没有任何肿瘤复发的迹象。通过分析我们中心使用乙状窦后入路对CPA肿瘤进行的47例完全神经内镜切除,我们相信这种方法允许完成,安全,有效切除CPA肿瘤,值得临床推广。
    The objective of this study is to preliminarily investigate the surgical safety, efficacy, techniques, and clinical value of fully neuroendoscopic surgery for the resection of cerebellopontine angle (CPA) tumors via a retrosigmoid approach. The clinical data of 47 cerebellopontine angle area (CPA) tumors that were treated by full neuroendoscopic surgery from June 2014 to June 2023 were retrospectively analyzed. The efficacy and advantages of the surgical techniques were evaluated based on indicators such as duration of the surgery, neuroendoscopic techniques, intraoperative integrity of nerves and blood vessels, extent of tumor resection, outcomes or postoperative symptoms, and incidence of complications. The 47 cases of cerebellopontine angle tumors include 34 cases of epidermoid cysts, 7 cases of vestibular schwannomas, and 6 cases of meningiomas. All patients underwent fully neuroendoscopic surgery. Twenty tumors were removed using the one-surgeon two-hands technique, and 27 tumors were removed using the two-surgeons four-hands technique. The anatomical integrity of the affected cranial nerves was preserved in all 47 cases. None of the patients suffered a postoperative hemorrhage, cerebrospinal fluid leak, and aseptic or septic meningitis, or died. The rate of total tumor resection was 72.3% (34/47), and the symptom improvement rate was 89.4% (42/47). All patients were followed up for 2 to 12 months, and none died nor showed any signs of tumor recurrence. By analyzing 47 fully neuroendoscopic resections of CPA tumors using the posterior sigmoid sinus approach in our center, we believe that such method allows complete, safe, and effective resection of CPA tumors and is thereby worthy of clinical promotion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究的目的是确定与前庭神经鞘瘤(VS)手术后面瘫相关的重要预后因素,并开发一种预测面神经(FN)结局的新列线图。
    方法:回顾性数据来自于2017年12月至2022年12月期间通过乙状窦后入路进行显微手术的355例患者。单因素和多因素logistic回归分析用于构建基于影像学特征的列线图以预测手术后面瘫的风险。
    结果:经过彻底的筛选过程,共纳入185名参与者.单因素和多因素logistic回归分析显示肿瘤大小(p=0.005),底液帽(FFC)符号(p=0.014),脑脊液裂(CSFC)征象(p<0.001),内耳道(IAC)患侧扩张(p=0.033)是独立因素。基于这些指标构建了列线图模型。当应用于验证队列时,列线图显示出良好的区分度和良好的校准。然后,我们生成了一个基于Web的计算器,以促进临床应用。
    结论:肿瘤大小,FFC和CSFC标志,以及IAC的扩展,作为术后FN结局的良好预测因子。基于这些因素,列线图模型显示出良好的预测性能。
    The purpose of this study was to identify significant prognostic factors associated with facial paralysis after vestibular schwannoma (VS) surgery and develop a novel nomogram for predicting facial nerve (FN) outcomes.
    Retrospective data were retrieved from 355 patients who underwent microsurgery via the retrosigmoid approach for VS between December 2017 and December 2022. Univariate and multivariate logistic regression analysis were used to construct a radiographic features-based nomogram to predict the risk of facial paralysis after surgery.
    Following a thorough screening process, a total of 185 participants were included. The univariate and multivariate logistic regression analysis revealed that tumor size (p = 0.005), fundal fluid cap (FFC) sign (p = 0.014), cerebrospinal fluid cleft (CSFC) sign (p < 0.001), and expansion of affected side of internal auditory canal (IAC) (p = 0.033) were independent factors. A nomogram model was constructed based on these indicators. When applied to the validation cohort, the nomogram demonstrated good discrimination and favorable calibration. Then we generated a web-based calculator to facilitate clinical application.
    Tumor size, FFC and CSFC sign, and the expansion of the IAC, serve as good predictors of postoperative FN outcomes. Based on these factors, the nomogram model demonstrates good predictive performance.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Multicenter Study
    目的:立体定向放射外科(SRS)术后前庭神经鞘瘤(VS)的瘤内出血(ITH)极为罕见。这项研究的目的是定义其发病率,并描述其管理和结果在这一子集的患者。
    方法:进行了一项回顾性多机构研究,在国际放射外科研究基金会下属的10个中心筛查9565例VS患者。
    结果:共有25例患者在SRS治疗后出现ITH(累积发生率为0.26%),ITH的中值尺寸为1.2cm3。大多数患者患有KoosII-IV级VS,中位年龄为62岁。ITH发展后,观察21例患者,2人进行了紧急手术干预,最初观察到2例,由于出血性扩张延迟和/或临床恶化,切除时间较晚.切除肿瘤的组织病理学表现典型,良性VS无硬化的组织学,伴随着慢性炎症细胞和多个出血片段。在最后一次随访中,17例患者改善,8例临床稳定。
    结论:VSSRS后的ITH极为罕见,但有各种临床表现和严重程度。管理范式应根据患者特定因素进行个性化处理,临床和/或放射学进展的速度,ITH扩张,和患者的整体状况。
    Intratumoral hemorrhage (ITH) in vestibular schwannoma (VS) after stereotactic radiosurgery (SRS) is exceedingly rare. The aim of this study was to define its incidence and describe its management and outcomes in this subset of patients.
    A retrospective multi-institutional study was conducted, screening 9565 patients with VS managed with SRS at 10 centers affiliated with the International Radiosurgery Research Foundation.
    A total of 25 patients developed ITH (cumulative incidence of 0.26%) after SRS management, with a median ITH size of 1.2 cm 3 . Most of the patients had Koos grade II-IV VS, and the median age was 62 years. After ITH development, 21 patients were observed, 2 had urgent surgical intervention, and 2 were initially observed and had late resection because of delayed hemorrhagic expansion and/or clinical deterioration. The histopathology of the resected tumors showed typical, benign VS histology without sclerosis, along with chronic inflammatory cells and multiple fragments of hemorrhage. At the last follow-up, 17 patients improved and 8 remained clinically stable.
    ITH after SRS for VS is extremely rare but has various clinical manifestations and severity. The management paradigm should be individualized based on patient-specific factors, rapidity of clinical and/or radiographic progression, ITH expansion, and overall patient condition.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:基于深度学习的分割算法通常需要大型或多机构数据集,以提高泛化的性能和能力。然而,当使用传统的集中学习(CL)时,保护患者隐私是多机构研究中的关键问题。
    目的:为了探索联合学习(FL)的立体定向放射外科(SRS)方案的拟议病变描绘的可行性,这可以解决权力下放和隐私保护问题。
    方法:回顾性。
    方法:来自两个研究所的506例和118例15-88岁和22-85岁的前庭神经鞘瘤患者,分别为1069例和256例脑膜瘤患者,年龄分别为12-91例和23-85例;574例和705例脑转移患者,年龄分别为26-92例和28-89例。
    5T,自旋回波,和梯度回波。
    结果:所提出的病变描绘方法被整合到FL框架中,建立CL模型作为基线。还探讨了图像标准化策略的效果。骰子系数用于评估预测的轮廓和地面实况之间的分割,这是由神经外科医生和神经放射学家手动描绘的。
    方法:应用配对t检验比较评价的骰子得分的平均值(p<0.05)。
    结果:FL对台北退伍军人总医院的测试集进行了与CL相当的平均骰子系数;对于台中退伍军人总医院的数据,CL显著(p<0.05)优于FL,而使用双参数,但使用单参数时的结果相当。对于非SRS数据,FL与平均骰子0.78对0.78(无标准化)的CL实现了可比的适用性,并优于两个研究所的基准模型。
    结论:所提出的病变勾画成功实施到FL框架中。FL模型适用于每个参与机构的SRS数据,在非SRS数据集上,FL表现出与CL相当的平均骰子系数。当使用FL时,将推荐标准化策略。
    方法:4技术效果:第一阶段。
    BACKGROUND: Deep learning-based segmentation algorithms usually required large or multi-institute data sets to improve the performance and ability of generalization. However, protecting patient privacy is a key concern in the multi-institutional studies when conventional centralized learning (CL) is used.
    OBJECTIVE: To explores the feasibility of a proposed lesion delineation for stereotactic radiosurgery (SRS) scheme for federated learning (FL), which can solve decentralization and privacy protection concerns.
    METHODS: Retrospective.
    METHODS: 506 and 118 vestibular schwannoma patients aged 15-88 and 22-85 from two institutes, respectively; 1069 and 256 meningioma patients aged 12-91 and 23-85, respectively; 574 and 705 brain metastasis patients aged 26-92 and 28-89, respectively.
    UNASSIGNED: 1.5T, spin-echo, and gradient-echo [Correction added after first online publication on 21 August 2023. Field Strength has been changed to \"1.5T\" from \"5T\" in this sentence.].
    RESULTS: The proposed lesion delineation method was integrated into an FL framework, and CL models were established as the baseline. The effect of image standardization strategies was also explored. The dice coefficient was used to evaluate the segmentation between the predicted delineation and the ground truth, which was manual delineated by neurosurgeons and a neuroradiologist.
    METHODS: The paired t-test was applied to compare the mean for the evaluated dice scores (p < 0.05).
    RESULTS: FL performed the comparable mean dice coefficient to CL for the testing set of Taipei Veterans General Hospital regardless of standardization and parameter; for the Taichung Veterans General Hospital data, CL significantly (p < 0.05) outperformed FL while using bi-parameter, but comparable results while using single-parameter. For the non-SRS data, FL achieved the comparable applicability to CL with mean dice 0.78 versus 0.78 (without standardization), and outperformed to the baseline models of two institutes.
    CONCLUSIONS: The proposed lesion delineation successfully implemented into an FL framework. The FL models were applicable on SRS data of each participating institute, and the FL exhibited comparable mean dice coefficient to CL on non-SRS dataset. Standardization strategies would be recommended when FL is used.
    METHODS: 4 TECHNICAL EFFICACY: Stage 1.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    当前治疗中小型前庭神经鞘瘤的指南建议要么预先进行放射外科治疗,要么等待放射学检查发现肿瘤生长。
    确定前期放射外科治疗小到中等大小的前庭神经鞘瘤是否比等待和扫描方法提供更好的肿瘤体积减小。
    对100例新诊断(<6个月)的单侧前庭神经鞘瘤患者进行随机临床试验,磁共振成像测得的桥小脑角最大肿瘤直径小于2cm。参与者从2014年10月28日至2017年10月3日在挪威国家前庭神经鞘瘤股注册;4年随访于2021年10月20日结束。
    参与者被随机分配接受预先放射外科(n=50)或接受等待和扫描协议,仅在影像学记录的肿瘤生长时给予治疗(n=50)。参与者进行了5次年度研究访问,包括临床评估,放射学检查,前庭检查,和问卷调查。
    主要结果是4年试验结束时的肿瘤体积与基线之间的比率(V4:V0)。有26个预设的次要结果,包括患者报告的症状,临床检查,前庭检查,和生活质量结果。安全性结果是挽救性显微外科手术和放射相关并发症的风险。
    在100名随机患者中,98人完成了试验,并被纳入主要分析(平均年龄,54岁;42%为女性)。在前期放射外科小组中,1名参与者(2%)在肿瘤生长后接受了重复的放射外科手术,2(4%)需要挽救显微外科手术,和45(94%)没有额外的治疗。在等待和扫描组中,21例患者(42%)在肿瘤生长后接受放射外科治疗,1人(2%)接受了挽救性显微外科手术,和28(56%)保持未处理。对于试验结束时肿瘤体积与基线之比的主要结果,前期放射外科组的几何平均值V4:V0为0.87(95%CI,0.66-1.15),等待扫描组为1.51(95%CI,1.23-1.84),在接受前期放射外科治疗的患者中显示出明显更大的肿瘤体积减少(等待和扫描与前期放射外科的比率,1.73;95%CI,1.23-2.44;P=.002)。在26个次要结果中,25无明显差别。未观察到辐射相关并发症。
    在新诊断的中小型前庭神经鞘瘤患者中,前期放射外科在4年时显示出明显大于等待和扫描方法的肿瘤体积减少。这些发现可能有助于前庭神经鞘瘤患者的治疗决策。需要进一步研究长期临床结局.
    ClinicalTrials.gov标识符:NCT02249572。
    Current guidelines for treating small- to medium-sized vestibular schwannoma recommend either upfront radiosurgery or waiting to treat until tumor growth has been detected radiographically.
    To determine whether upfront radiosurgery provides superior tumor volume reduction to a wait-and-scan approach for small- to medium-sized vestibular schwannoma.
    Randomized clinical trial of 100 patients with a newly diagnosed (<6 months) unilateral vestibular schwannoma and a maximal tumor diameter of less than 2 cm in the cerebellopontine angle as measured on magnetic resonance imaging. Participants were enrolled at the Norwegian National Unit for Vestibular Schwannoma from October 28, 2014, through October 3, 2017; 4-year follow-up ended on October 20, 2021.
    Participants were randomized to receive either upfront radiosurgery (n = 50) or to undergo a wait-and-scan protocol, for which treatment was given only upon radiographically documented tumor growth (n = 50). Participants underwent 5 annual study visits consisting of clinical assessment, radiological examination, audiovestibular tests, and questionnaires.
    The primary outcome was the ratio between tumor volume at the trial end at 4 years and baseline (V4:V0). There were 26 prespecified secondary outcomes, including patient-reported symptoms, clinical examinations, audiovestibular tests, and quality-of-life outcomes. Safety outcomes were the risk of salvage microsurgery and radiation-associated complications.
    Of the 100 randomized patients, 98 completed the trial and were included in the primary analysis (mean age, 54 years; 42% female). In the upfront radiosurgery group, 1 participant (2%) received repeated radiosurgery upon tumor growth, 2 (4%) needed salvage microsurgery, and 45 (94%) had no additional treatment. In the wait-and-scan group, 21 patients (42%) received radiosurgery upon tumor growth, 1 (2%) underwent salvage microsurgery, and 28 (56%) remained untreated. For the primary outcome of the ratio of tumor volume at the trial end to baseline, the geometric mean V4:V0 was 0.87 (95% CI, 0.66-1.15) in the upfront radiosurgery group and 1.51 (95% CI, 1.23-1.84) in the wait-and-scan group, showing a significantly greater tumor volume reduction in patients treated with upfront radiosurgery (wait-and-scan to upfront radiosurgery ratio, 1.73; 95% CI, 1.23-2.44; P = .002). Of 26 secondary outcomes, 25 showed no significant difference. No radiation-associated complications were observed.
    Among patients with newly diagnosed small- and medium-sized vestibular schwannoma, upfront radiosurgery demonstrated a significantly greater tumor volume reduction at 4 years than a wait-and-scan approach with treatment upon tumor growth. These findings may help inform treatment decisions for patients with vestibular schwannoma, and further investigation of long-term clinical outcomes is needed.
    ClinicalTrials.gov Identifier: NCT02249572.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号